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Background: Substance use disorders (SUD) are patterns of substance use leading
to severe impairment on social, working and economic levels. In vivo and clinical
findings have enhanced the role of the brain’s stress-related system in maintaining
SUD behaviors. Several studies have also revealed a high prevalence of post-traumatic
symptoms among SUD patients, suggesting that a trauma-informed treatment approach
could lead to better treatment outcomes. However, only few studies have evaluated
the use of eye movement desensitization and reprocessing (EMDR) in SUD without
consistent results. The aim of the present pilot study was to assess the efficacy of a
combined trauma-focused (TF) and addiction-focused (AF) EMDR intervention in treating
post-traumatic and stress-related symptoms of patients with SUD.
Methods: Forty patients with different SUD were enrolled in the study. Twenty patients
underwent treatment as usual (TAU), the other 20 patients were treated with TAU plus 24
weekly sessions of EMDR. All patients were assessed before and after intervention for
several psychological dimensions using specific tools (i.e., BDI-II, DES, IES-R, STAI, and
SCL-90-GSI). A repeated measure MANOVA was performed to evaluate both between
groups (TAU + EMDR vs. TAU) and within group (pre- vs. post-intervention) effects and
interactions. A secondary outcome was the dichotomous variable yielded by the urine
drug testing immunoassay (yes/no).
Results: The RM-MANOVA revealed both a significant pre–post main effect (p< 0.001),
and a significant group-by-time main effect (p < 0.001). Significant improvements on
IES-R, DES, and SCL-90-GSI scales were shown in both groups according to time effects
(p < 0.05). However, significant greater effects were found for TAU + EMDR group than
TAU group. No differences were found between TAU and TAU + EMDR groups in terms
of urine drug immunoassay results before and after the interventions.
Conclusions: The TAU + EMDR group showed a significant improvement of
post-traumatic and dissociative symptoms, accompanied by a reduction in anxiety and
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overall psychopathology levels, whereas TAU group showed a significant reduction only
in post-traumatic symptoms. Although our results can only be considered preliminary,
this study suggests that a combined TF- and AF- EMDR protocol is an effective and
well-accepted add-on treatment for patients with SUD.
Keywords: eye movement desensitization and reprocessing, substance use disorder, traumatic stress,
dissociation, anxiety, depression, psychiatric symptoms, adverse childhood experiences
INTRODUCTION
Substance use disorders (SUD) are pathological patterns of
behaviors related to substance use leading to severe impairment
of familial, social and working relationships as well as of
economic conditions (American Psychiatric Association, 2013).
Although the neurobiological circuitry that is associated with
drug reward has been broadened in recent years, the meso-
cortical-striatal dopamine system is still the most important
pathway involved in the rewarding properties of almost all drugs
(Koob and Volkow, 2016).
However, in vivo and clinical findings have also enhanced
the role of brain’s stress-related system in maintaining SUD
behaviors: the chronic administration of all major drugs with
dependence or abuse potential is associated with corticotropin-
releasing factor variation leading to both hypothalamic-pituitary-
adrenal axis and brain stress system dysregulation (Koob, 2013).
The increase of corticotropin-releasing factor, dynorphin, and
norepinephrine recruited in the extended amygdala contributes
to the development of negative emotional states during acute
withdrawal (such as chronic irritability, dysphoria, and loss of
motivation; Koob and Volkow, 2016).
From an epidemiologic point of view, patients having any
lifetime SUD showed higher risk of also having a post-traumatic
stress disorder (PTSD; OR = 1.6, 95% CI = 1.27–2.10, Grant
et al., 2016) with a prevalence of current PTSD ranging from 15
to 42% (Mills et al., 2005; Reynolds et al., 2005, 2011; Driessen
et al., 2008).
Moreover, some studies conducted on SUD showed that 67–
92% of the patients report having experienced at least one
traumatic event according to the DSM-IV PTSD criterion A
(Dragan and Lis-Turlejska, 2007; Reynolds et al., 2011).
Furthermore, several studies have also reported a strong
relationship between exposure to severe stress in childhood and
substance abuse (Dube et al., 2003; Green et al., 2010). One of
the most important studies, conducted by the Center for Disease
Control along with the Kaiser Hospital in San Diego, released the
landmark Adverse Childhood Experience (ACE) study, showing
that individuals who experienced four or more types of ACEs
were at a four to 12-fold increased risk of developing alcohol or
drug abuse problems (Felitti et al., 1998).
Research has shown that substance abuse treatment using
a trauma-informed approach could lead to better treatment
outcomes, such as greater symptom reduction and increased
retention in treatment (Amaro et al., 2007; LeTendre and Reed,
2017).
Such involvement of stress systems, trauma, and PTSD in SUD
suggested a possible role of intervention possibly impacting on
traumatic and stress disorders in the treatment of patients with
SUD.
Among the different psychological approaches, eye movement
desensitization and reprocessing (EMDR) has emerged as an
evidence-based therapy for the treatment of psychological
sequelae of traumatic events and other negative stressful
experiences (Shapiro, 2014).
EMDR is a psychotherapeutic approach that focuses on
trauma elaboration. It is guided by the adaptive information
processing (AIP) model, that posits that stressful events
not fully processed and integrated into the already existing
memory networks are stored in a dysfunctional way. A distinct
characteristic of EMDR therapy is the use of alternating
bilateral stimulation (eye movements, tactile, or audio), which
appears to produce a physiological effect promoting accelerated
reprocessing of dysfunctionally stored information related to the
traumatic event (Jeffries and Davis, 2013; Carletto et al., 2017;
Pagani et al., 2017).
EMDR is considered one of the elective psychotherapeutic
treatments for PTSD, according to several meta-analyses and
clinical guidelines (Van Etten and Taylor, 1998; Davidson and
Parker, 2001; Bradley et al., 2005; National Collaborating Centre
for Mental Health, 2005; Bisson et al., 2013; WHO, 2013;
Chen et al., 2014, 2015) and its neurobiological effects are also
supported by neuroimaging findings (Pagani et al., 2012, 2015;
Boukezzi et al., 2017).
Furthermore, in recent years the use of EMDR has expanded
beyond PTSD and several studies have reported its efficacy
for treatment of trauma-associated symptoms in patients with
other psychiatric conditions (for a review see Valiente-Gómez
et al., 2017). Among these, several protocols of treatment were
developed in order to address traumatic experiences of SUD
patients.
The clinical application of trauma-focused EMDR (TF-
EMDR) in some studies resulted in EMDR being efficacious
in the treatment of traumatic symptoms, but not in addiction
behavior severity (see reviews by Roberts et al., 2015 and Markus
and Hornsveld, 2017). Subsequently, some authors focused on
the role of TF-EMDR in patients with SUD without PTSD,
considering different types of outcomes even in relation to the
addiction with fairly positive results but without conclusive
findings.
Finally, as a third possible application of EMDR in SUD,
there were some proposals of addiction-focused EMDR (AF-
EMDR) protocols, such as the desensitization of triggers and urge
reprocessing (DeTUR) protocol by Popky (2005), the feeling-
state addiction protocol (FSAP) by Miller (2010) and the craving
extinguished (CravEx) protocol by Hase et al. (2008). All these
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protocols were specifically focused on the addiction rather
on trauma but only the CravEx was clinically evaluated in a
randomized clinical trial. Comparing treatment as usual (TAU)
with CravEx plus TAU in a sample of patients with alcohol use
disorder, Hase et al. (2008) have found a significant reduction in
craving and depression severity up to 1 month after treatment.
To the best of our knowledge, no studies have yet evaluated
the efficacy of both trauma and addiction-focused protocols on
the relapse rate and stress-related symptoms of patients with
SUD. Therefore, the aim of the present pilot study was to
assess the efficacy of a combined trauma-focused and addiction-
focused EMDR protocol in treating post-traumatic and stress-
related symptoms of patients with SUD. We hypothesized that
this combined adjunctive EMDR intervention would be more
effective than a TAU intervention.
MATERIALS AND METHODS
Design
This was a quasi-experimental study investigating the efficacy of
an additional EMDR treatment as compared with TAU alone in
patients diagnosed with SUD.
Setting
The participants were recruited in two settings: an outpatient
territorial service for drug addiction in northern Italy (Ser.T. of
Limbiate, MI) and a residential facility in central Italy (Comunità
di Capodarco di Fermo, FM) fromMarch 2015 to May 2016.
The study was approved by the Medical Ethics Committee of
Azienda Territoriale dei Servizi of Brianza (MB, Italy) and by the
Board of Directors of Capodarco (FM, Italy). Informed written
consent was obtained from all the participants.
Participants
The subjects of the study were patients with a diagnosis of SUD,
who were referred to one of the two above-mentioned centers for
drug addiction treatment.
Inclusion criteria were as follows: (1) a diagnosis of SUD,
according to DSM-5; (2) age between 18 and 65 years; (3) fluent
Italian language; (4) legal capacity to consent to the treatment; (5)
maintenance of psychotropic medications throughout the study.
Exclusion criteria were as follows: (1) having a pathological
gambling disorder without comorbidity with other SUDs; (2)
presence of other severe psychiatric disorders such as psychosis
or bipolar disorder; (3) cognitive disorders such as overt
dementia; (4) suicide attempts; (5) current pregnancy.
Assessment
The recruitment of participants was carried out by a psychiatrist
and psychologist who proposed participation in the research
protocol to patients during a clinical visit in the outpatient setting
and during the first visit after admission in the inpatient setting.
The research protocol was proposed to consecutive patients
who met the inclusion criteria, with an explanation of the
aims of the study, and patients were asked whether they were
willing to receive an additional psychotherapeutic intervention
(EMDR) other than TAU. Patients could choose the group to
which they wanted to be assigned (TAU or TAU + EMDR). On
reaching the maximum number of patients in the TAU+ EMDR
group, the remaining patients were assigned to the TAU alone
group.
The psychological assessment was performed by psychologists
independent of the research protocol, using the same timing and
tools, i.e., at baseline before the first session of treatment (T0),
and after the end of treatment (T1).
The following psychological self-report questionnaires were
administered:
Impact of Event Scale—Revised (IES-R). The IES-R (Weiss and
Marmar, 1997) is a 22- item self-report questionnaire consisting
of three subscales (eight items relate to intrusions, eight items
evaluate avoidance, and six items assess hyperarousal). The scale
assesses subjective distress caused by traumatic events. An IES-R
score equal to or >33 represents the best cut-off for a probable
diagnosis of PTSD. The IES-R was found to be highly internally
consistent (Cronbach’s alpha, α= 0.96; Creamer et al., 2003).
State-Trait Anxiety Inventory (STAI-Y). The STAI-Y
(Spielberger et al., 1983) is used to measure the presence
and severity of current symptoms of anxiety (state anxiety;
STAI-1) and a generalized propensity to be anxious (trait anxiety;
STAI-2). Range of scores for each subtest is 20–80, the higher
score indicating greater anxiety. A cutoff point of 39–40 has been
suggested to detect clinically significant symptoms for the state
anxiety scale. The STAI-Y has shown an adequate to excellent
internal reliability (α= 0.86–0.95).
Beck Depression Inventory-II (BDI-II). The BDI-II (Beck and
Steer, 1993) is a 21-item self-report instrument that assesses the
presence and severity of depression symptoms. A score above
13 indicates presence of depression symptoms. The internal
consistency of the BDI-II is good to excellent (α = 0.83–0.96;
Wang and Gorenstein, 2013).
Symptom Checklist 90 Items revised version (SCL-90- R)
(Derogatis et al., 1973; Derogatis, 1994) is a 90-items self-report
questionnaire that evaluates a broad range of psychological
problems and symptoms of psychopathology. For the purpose of
this study we chose to utilize the Global Severity Index (GSI),
as it represents the best global indicator of the intensity of
psychic distress reported by the subject and it demonstrated a
high Cronbach’s alpha value (α = 0.97; Prinz et al., 2013). This
global index combines information about the number of reported
symptoms and the intensity of perceived discomfort. A score
between 55 and 65 indicates a distress level of moderate intensity,
while a score above 65 reveals a severe intensity of discomfort,
beyond the threshold of clinical attention.
Dissociative Experiences Scale (DES) (Bernstein and Putnam,
1986; Frischholz et al., 1990) is a brief, 28-item, self-report
inventory of the frequency of dissociative experiences. It
represents a reliable and valid measure for determining the
contribution of dissociation to various psychiatric disorders and
a screening instrument for dissociative disorders. High levels of
dissociation are indicated by scores of 30 or more. The DES has
an excellent internal consistency, with Cronbach’s alpha ranging
from 0.96 to 0.97 (Dubester and Braun, 1995).
The Adverse Childhood Experience Questionnaire (ACE)
(Felitti et al., 1998) is a 10-item self-report measure developed
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for the ACE study to identify childhood experiences of abuse
and neglect. The internal consistency of the ACE questionnaire
is adequate (α = 0.88; Murphy et al., 2014). This questionnaire
was administered only at baseline.
Treatments
Treatment as Usual
All patients received TAU, which consisted of standard treatment
for recovery from SUD in the National Health Service in Italy.
TAU included clinical interviews with the addiction specialist
and administration of medications appropriate for each patient
(e.g., alcohol craving, heroin substitute treatment). Comorbid
psychiatric conditions such as depression or anxiety disorders
were treated in accordance with the patient’s needs, including
appropriate medication.
Lastly, TAU included psychological treatment (both
individual and group sessions) and participation in
psycho-educational group sessions.
Eye Movement Desensitization and Reprocessing
Participants received 24 weekly EMDR sessions over a period of
6 months. The EMDR treatment used in this study incorporated
both elements of the classic TF-EMDR protocol (Shapiro,
2001) and of the existing AF-EMDR protocols (Hase, 2010;
Knipe, 2010; Miller, 2010; Popky, 2010), in accordance with the
Palette of EMDR Interventions in Addiction (PEIA; Markus and
Hornsveld, 2017).
The EMDR treatment steps were as follows:
1) Building a positive therapeutic relationship;
2) Information gathering (trauma history, addiction history);
3) Strengthening the motivation for treatment through positive
and achievable therapeutic goals and enhancing personal
resources;
4) Desensitization of traumatic events in chronological order;
5) Desensitization of the “first time” memory and the
dependence of precipitating factors;
6) Desensitization of the level of urge;
7) Desensitization of the recall of the relapse;
8) Desensitizing triggers of triggering behavior;
9) Installing a positive state for each triggering factor.
EMDR treatment was provided by four clinical psychotherapists
specialized in EMDR therapy (who at least had completed the
Level II EMDR program). The EMDR therapists were supervised
monthly by an EMDR consultant.
Statistical Analyses
Data were processed and analyzed using the Statistical Package
for Social Sciences (SPSS version 22.0; Chicago, IL, USA).
Both parametric and nonparametric tests were used, in
accordance with Shapiro–Wilk as a test for normality. Baseline
group differences were assessed using Student’s t-test or Mann–
Whitney U-test to compare the two groups for continuous
measures and Fisher’s Exact Test for categorical measures.
GLM repeated measures multivariate ANOVA (RM-
MANOVA) was used to analyze the main pre- and post-
intervention effects and interactions both between and within
TAU + EMDR and TAU groups. Pairwise comparison between
groups were made by simple contrast and are reported as means
difference with the Sidak correction 95% confidence interval
(95%CI) for multiple comparisons.
A p < 0.05 was considered statistically significant throughout
all of the analyses.
RESULTS
A total of 40 patients were enrolled in the study: 20 were assigned
to the TAU+ EMDR intervention and the other 20 patients were
assigned to the TAU treatment. We did not register any dropout
from the treatments.
Table 1 presents the sociodemographic characteristics of these
patients at baseline. There were no significant differences in
demographics between the two groups at baseline (T0), except
for adverse childhood experiences, which were more frequent in
the TAU+ EMDR group (Table 1).
There were several differences between the two groups at
baseline. Overall, patients in the TAU + EMDR group showed
higher post-traumatic stress and anxiety symptoms and more
psychiatric symptoms.
We evaluated whether the different psychotherapy treatments
(TAU + EMDR or TAU) administered to the patients had
a different impact on the psychological variables of interests.
A repeated-measures MANOVA was performed on the pre-
and post-intervention clinical scores (IES-R, DES, SCL-90-GSI,
TABLE 1 | Demographic data of participants at baseline.
EMDR (N = 20)
Mean (SD)/
Median (IQR)
TAU (N = 20)
Mean (SD)/
Median (IQR)
p
Age (years) 32 (8) 32 (19) 0.820a
Years of substance use 19.40 (7.98) 21.10 (9.59) 0.546b
Adverse Childhood Experiences 4 (5) 2 (2) 0.004a
n (%) n (%)
Gender 0.487c
Female 2 (10) 0 (0)
Male 18 (90) 20 (100)
Marital status 0.410c
Single 17 (85) 14 (70)
Married 1 (5) 4 (20)
Separated/divorced 2 (10) 2 (10)
Level of education 0.198c
Primary school 0 (0) 3 (15)
Low secondary school 9 (45) 10 (50)
High secondary school 11 (55) 7 (35)
EMDR, Eye Movement Desensitization and Reprocessing group; TAU, Therapy As Usual
group.
aMann–Whitney U-test.
bPearson’s independent samples t-test.
cFisher’s exact test.
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STAI-1, STAI-2, BDI-II), comparing group and time effects and
interactions between group and time.
The RM-MANOVA yielded a significant pre–post main effect
[F(6, 33) = 10.102, p < 0.001; η
2
p = 0.647], and a significant
interaction between the pre–post measures and the treatment
condition [F(6, 33) = 7.830, p < 0.001; η
2
p = 0.587].
Significant time effects were found across both groups for
all variables except for STAI-1 and STAI-2, indicating that the
mean participant scores improved from time 0 (pre-intervention)
to time 1 (post-intervention) on all variables except for anxiety
symptoms (Table 2).
Group-by-time interaction effects were found for IES-R, DES,
SCL-90-GSI, STAI-1, and STAI-2 total scores, indicating that
clinical improvements regarding these variables were different
in the two treatment groups. No group-by-time interaction was
found for BDI-II, showing that change on this measure was
similar for both treatment groups (Table 2).
Planned post-hoc analyses of simple effects of pre–post were
conducted for all variables with a significant group-by-time
effect (DES, IES-R, SCL-90-GSI, STAI-1, STAI-2,) by GLM
pairwise comparisons using the Sidak adjustment for multiple
comparisons.
The two groups significantly differ for IES-R scores at baseline,
with participants in the TAU + EMDR group showing higher
post-traumatic symptoms than those in the TAU group (Table 2).
The analysis of simple effects over time indicated both groups had
an improvement in post-traumatic symptoms (Table 3), but the
TAU + EMDR group scored significantly lower compared to the
TAU group at post-treatment (Table 2).
As regards the DES score, there was no significant difference
between groups at baseline (Table 2). Results indicated that
the group-by-time effect is explained by the significant
difference between dissociative pre- and post-treatment scores
for participants who underwent EMDR intervention (Table 3).
Moreover, there was also a difference between groups
at baseline for the SCL-90-GSI score, with more severe
psychiatric symptoms in the TAU + EMDR group (Table 2).
The comparison between pre- and post-treatment indicated a
significant improvement in the TAU+ EMDR group between T0
and T1, while there was no difference in the TAU group (Table 3).
In the case of STAI-1, results indicated that there was
a significant difference between the two groups at baseline,
as the STAI-1 scores at baseline in TAU + EMDR group
were significantly higher than those in TAU group (Table 2).
Concurrently, there was a significant difference between STAI-
1 pre- and post-treatment scores in the TAU group but not
in the TAU + EMDR group. This indicates that the group-by-
time effect was due to the significant difference between groups
at baseline and to the significant worsening of state anxiety
symptoms in patients in the TAU group (Table 3).
With regard to STAI-2, a significant difference between the
two groups at baseline was found, as STAI-2 scores at baseline
in TAU + EMDR group were significantly higher than those in
TAU group (Table 2). Moreover, there was a significant reduction
of STAI-2 scores in the TAU+ EMDR group that was not present
in the TAU group. This indicates that the improvements over
time on trait anxiety were registered only in the TAU+ EMDR
treatment group (Table 3).
No differences were found before and after treatment in
the urine drug testing immunoassays, which showed a similar
increase of negative results after the interventions (TAU group
from 65% at baseline to 85% at T1; TAU + EMDR group from
70% at baseline to 80% at T1; χ2 = 0.067, p= 0.795).
DISCUSSION
Overall, all SUD patients included in the study improved their
clinical condition with a significant reduction of post-traumatic,
dissociative and psychiatric symptoms, regardless of the type of
treatment.
Both TAU and TAU + EMDR interventions had a significant
effect in reducing post-traumatic symptoms, but the add-on
EMDR proved to have a significant greater effect, allowing a shift
from baseline levels above the clinical cut-off to post-treatment
normal levels. This finding is in line with those of previous
studies (Perez-Dandieu and Tapia, 2014; Brown et al., 2015),
which showed that adding EMDR to TAU has a significant effect
on post-traumatic symptoms.
In the same way, according to the results of the present
study, the add-on EMDR has an important effect in reducing
TABLE 2 | Comparison of clinical variables for the two groups (TAU and TAU + EMDR).
Pre-treatment p Post-treatment p Effect Time Effect Time × Group
TAU
(N = 20)
TAU + EMDR
(N = 20)
TAU
(N = 20)
TAU + EMDR
(N = 20)
F P η2p F P η
2
p
BDI-II 11.60 (7.45) 18.35 (14.08) 0.066 10.10 (7.58) 11.65 (12.54) 0.639 8.646 0.006 0.185 3.477 0.070 0.084
STAI-1 41.95 (4.17) 46.35 (5.26) 0.006 46.25 (5.28) 43.50 (5.31) 0.109 0.459 0.502 0.012 11.160 0.002 0.227
STAI-2 42.05 (2.69) 45.65 (5.49) 0.012 43.20 (3.14) 42.60 (7.61) 0.746 1.476 0.232 0.037 7.212 0.011 0.160
DES 10.93 (8.07) 15.69 (14.05) 0.196 8.53 (6.67) 6.72 (7.13) 0.411 15.766 <0.001 0.293 5.279 0.027 0.122
IES-R 23.90 (15.35) 39.65 (23.12) 0.015 12.30 (11.76) 6.05 (5.88) 0.040 48.282 <0.001 0.560 11.438 0.002 0.231
SCL-90-GSI 62.65 (10.39) 73.90 (2.94) <0.001 61.95 (11.55) 63.25 (12.37) 0.733 14.378 0.001 0.275 11.050 0.002 0.225
Data are mean (SD).
TAU, Therapy As Usual group;
TAU + EMDR, Eye Movement Desensitization and Reprocessing in addition to TAU group.
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TABLE 3 | Comparison between T0 and T1 of clinical variables for the two groups (TAU and TAU + EMDR).
TAU TAU + EMDR
T0 T1 Mean difference (95%CI) p T0 T1 Mean difference (95%CI) p
BDI-II 11.60 (7.45) 10.10 (7.58) −1.500 (−5.492; 2.492) 0.452 18.35 (14.08) 11.65 (12.54) −6.700 (−10.692; −2.708) 0.002
STAI-1 41.95 (4.17) 46.25 (5.28) 4.300 (1.236; 7.384) 0.007 46.35 (5.26) 43.50 (5.31) −2.850 (−5.914; 0.214) 0.067
STAI-2 42.05 (2.69) 43.20 (3.14) 1.150 (−1.089; 3.389) 0.305 45.65 (5.49) 42.60 (7.61) −3.050 (−5.289; −0.811) 0.009
DES 10.93 (8.07) 8.53 (6.67) −2.395 (−6.493; 1.703) 0.244 15.69 (14.05) 6.72 (7.13) −8.973 (−13.071; −4.874) <0.001
IES-R-Total 23.90 (15.35) 12.30 (11.76) −11.600 (−20.912; −2.288) 0.016 39.65 (23.12) 6.05 (5.88) −33.600 (−42.912; −24.288) <0.001
SCL-90 Total 62.65 (10.39) 61.95 (11.55) −0.700 (−4.985; 3.585) 0.743 73.90 (2.94) 63.25 (12.37) −10.650 (−14.935; −6.365) <0.001
Data are mean (SD).
TAU, Therapy As Usual group;
TAU + EMDR, Eye Movement Desensitization and Reprocessing in addition to TAU group.
dissociative symptoms, probably due to the well-recognized effect
of EMDR on the reintegration of previous dysfunctionally stored
memories (Nardo et al., 2013; van der Hart et al., 2013).
As regards the effect of EMDR on stress-related psychiatric
symptoms, a significant improvement in the global severity of
psychiatric symptoms was observed in patients who received
add-on EMDR as compared to TAU alone, suggesting that EMDR
also has a beneficial impact on a wide range of symptoms of
clinical relevance, beyond post-traumatic symptoms.
In terms of anxiety, our results show a significant effect of
add-on EMDR in improving trait anxiety that is not shown
in TAU alone. In spite of its tendency to be stable over
time, a number of studies revealed that trait anxiety can
improve as a result of a psychological intervention over time
(Vøllestad et al., 2011; Lee et al., 2015). Our results suggest
that EMDR intervention might also affect the trait-like tendency
to experience anxiety over time and across situations. Another
interesting finding of our study is that state anxiety worsened
in the TAU alone group, whereas in the TAU + EMDR group
it remained stable. An increase of anxiety levels, mediated
by adrenocorticotropic hormone, corticosterone, and amygdala
corticotrophin releasing factor (CRF), is commonly observed
during acute withdrawal stages of substance treatment and
recovery programs (Koob and Volkow, 2016). It would seem that
the TAU alone does not impact on this increase in anxiety levels,
whereas the add-on of an EMDR intervention seems to be able to
counterbalance this physiological elevation of anxiety related to
abstinence.
With regard to depressive symptoms, no significant change
was observed in either group, although our findings suggest a
trend toward improvement in the group that received add-on
EMDR, partially confirming previous findings (Hase et al., 2008;
Perez-Dandieu and Tapia, 2014).
This study presents a methodological limitation that may
moderate the interpretation of the results outlined so far. The
non-randomized design led to the significant differences between
the two groups at baseline. In fact, participants who received
EMDR treatment showed higher baseline levels of symptoms
compared to the group receiving only TAU treatment. These
differences at baseline could limit a conclusive interpretation of
the results of the study, as the improvements obtained by the
group that received EMDR in addition to TAU could also be due
to a spontaneous reduction of symptoms linked to the fact that
higher reductions are observed when there are higher starting
levels.
At the same time, the findings of the present study
suggest that EMDR may be more useful in subjects who
experienced more adverse childhood experiences and higher
levels of symptoms, in order to strengthen standard treatment
that otherwise would only be partially effective, especially
on withdrawal-related anxiety. Consistent with previous
literature reporting that adverse childhood events have
significant implications for substance abuse treatment and
that a trauma-informed approach to SUD leads to better
treatment outcomes (Felitti et al., 1998; LeTendre and Reed,
2017), our findings suggest that exposure to adverse childhood
experiences should be routinely assessed in treatment settings,
in order to provide specific interventions to reduce traumatic
burden associated with SUD. Future randomized controlled
studies with larger samples should better investigate these
aspects.
Another limit of the present study is that aspects related to
craving and abstinence were not specifically investigated. The
results of our study are in line with previous studies, which show
that EMDR has beneficial effects on symptoms related to the
traumatic history and only limited effects on additional outcomes
(Markus and Hornsveld, 2017). The present study aimed to
focus on post-traumatic and associated aspects linked to the
relationship between addiction and traumatic burden, but future
studies on similar populations should also take into account
addict-related aspects.
This study also has some strengths. The results of the study
confirm that EMDR could be a viable and well-accepted add-
on treatment for patients with SUD, with some evidence of
both efficacy and good compliance. Moreover, to the best of
our knowledge this is the first study evaluating the clinical
impact of an add-on EMDR intervention focused on both
traumatic and addiction-related memories, and it found the first
promising evidence of the efficacy of this combined TF- and AF-
EMDR protocol. Further studies could evaluate the usefulness
of combining TF- and AF-EMDR protocols in different clinical
samples.
Although our results can only be considered preliminary,
this study suggests that add-on EMDR is more effective
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than TAU alone in improving post-traumatic and dissociative
symptoms, accompanied also by a reduction in anxiety and
overall psychopathology levels.
The findings of this study underline the importance
of assessing ACEs and other traumatic experiences in
this population because they may contribute to the onset
and maintenance of SUDs and lead to a worsening of
psychopathological severity. As a clinical consequence, it
could be useful to offer these patients specific add-on treatments
addressing both ACEs and traumatic experiences related to
addiction, in adjunction to standard treatments.
Future studies, such as that designed by Markus et al. (2015)
on alcohol-dependent patients, would be better to investigate
not only the effectiveness of an EMDR add-on treatment but
also the mediators, moderators, and predictors of treatment
outcome, in order to be able to delineate effective interventions
for these disorders, which represent a major public health
problem.
AUTHOR CONTRIBUTIONS
MB is the national coordinator of the research. MB, IF, and
MP were responsible for the conception and the design of
the study. MB, TA, AC, PM, CR, and IF were responsible for
data collection and for clinical treatments. SC and FO were
responsible for the data analysis. IF, MB, LO, andMP contributed
to the interpretation of data. SC and FO wrote the article, which
was critically revised by all the others authors. All authors have
approved the final version of the manuscript.
ACKNOWLEDGMENTS
We would like to thank the participants involved in the study
for their time and effort. We are also grateful to all the staff of
ASST Monza and Comunità di Capodarco di Fermo for their
contribution and unstinting support during the entire study
period.
REFERENCES
Amaro, H., Chernoff, M., Brown, V., Arévalo, S., and Gatz, M. (2007). Does
integrated trauma-informed substance abuse treatment increase treatment
retention? J. Commun. Psychol. 35, 845–862. doi: 10.1002/jcop.20185
American Psychiatric Association (2013). Diagnostic and Statistical Manual
of Mental Disorders: Dsm-5. Washington, DC: American Psychiatric Pub
Incorporated.
Beck, A., and Steer, R. (1993). Manual for the Beck Depression Inventory. San
Antonio, TX: Psychological Corporation.
Bernstein, E. M., and Putnam, F. W. (1986). Development, reliability,
and validity of a dissociation scale. J. Nerv. Ment. Dis. 174, 727–735.
doi: 10.1097/00005053-198612000-00004
Bisson, J. I., Roberts, N. P., Andrew, M., Cooper, R., and Lewis, C.
(2013). Psychological therapies for chronic post-traumatic stress
disorder (PTSD) in adults. Cochrane Database Syst. Rev. CD003388.
doi: 10.1002/14651858.CD003388.pub4
Boukezzi, S., El Khoury-Malhame, M., Auzias, G., Reynaud, E., Rousseau, P.-
F., Richard, E., et al. (2017). Grey matter density changes of structures
involved in Posttraumatic Stress Disorder (PTSD) after recovery following Eye
Movement Desensitization and Reprocessing (EMDR) therapy. Psychiatry Res.
266, 146–152. doi: 10.1016/j.pscychresns.2017.06.009
Bradley, R., Greene, J., Russ, E., Dutra, L., and Westen, D. (2005). A
multidimensional meta-analysis of psychotherapy for PTSD. Am. J. Psychiatry
162, 214–227. doi: 10.1176/appi.ajp.162.2.214
Brown, S. H., Gilman, S. G., Goodman, E. G., Adler-Tapia, R., and Freng, S. (2015).
Integrated trauma treatment in drug court: combining EMDR therapy and
seeking safety. J. EMDR Pract. Res. 9, 123–136. doi: 10.1891/1933-3196.9.3.123
Carletto, S., Borsato, T., and Pagani, M. (2017). The role of slow wave
sleep in memory pathophysiology: focus on post-traumatic stress disorder
and eye movement desensitization and reprocessing. Front. Psychol. 8:2050.
doi: 10.3389/fpsyg.2017.02050
Chen, L., Zhang, G., Hu, M., and Liang, X. (2015). Eye movement desensitization
and reprocessing versus cognitive-behavioral therapy for adult posttraumatic
stress disorder: systematic review and meta-analysis. J. Nerv. Ment. Dis. 203,
443–451. doi: 10.1097/NMD.0000000000000306
Chen, Y.-R., Hung, K.-W., Tsai, J.-C., Chu, H., Chung, M.-H., Chen, S.-R., et al.
(2014). Efficacy of eye-movement desensitization and reprocessing for patients
with posttraumatic-stress disorder: a meta-analysis of randomized controlled
trials. PLoS ONE 9:e103676. doi: 10.1371/journal.pone.0103676
Creamer, M., Bell, R., and Failla, S. (2003). Psychometric properties of
the impact of event scale—revised. Behav. Res. Ther. 41, 1489–1496.
doi: 10.1016/j.brat.2003.07.010
Davidson, P. R., and Parker, K. C. H. (2001). Eye movement desensitization and
reprocessing (emdr): a meta-analysis. J. Consult. Clin. Psychol. 69, 305–316.
doi: 10.1037/0022-006X.69.2.305
Derogatis, L. R. (1994). SCL-90-R : Symptom Checklist-90-R : Administration,
Scoring & Procedures Manual. Minneapolis, MN: National Computer Systems,
Inc.
Derogatis, L. R., Lipman, R. S., and Covi, L. (1973). SCL-90: an outpatient
psychiatric rating scale–preliminary report. Psychopharmacol. Bull. 9, 13–28.
Dragan, M., and Lis-Turlejska, M. (2007). Prevalence of posttraumatic stress
disorder in alcohol dependent patients in Poland. Addict. Behav. 32, 902–911.
doi: 10.1016/j.addbeh.2006.06.025
Driessen, M., Schulte, S., Luedecke, C., Schaefer, I., Sutmann, F., Ohlmeier,
M., et al. (2008). Trauma and PTSD in patients with alcohol, drug, or
dual dependence: a multi-center study. Alcohol. Clin. Exp. Res. 32, 481–488.
doi: 10.1111/j.1530-0277.2007.00591.x
Dube, S. R., Felitti, V. J., Dong, M., Chapman, D. P., Giles, W. H., and Anda,
R. F. (2003). Childhood abuse, neglect, and household dysfunction and the
risk of illicit drug use: the adverse childhood experiences study. Pediatrics 111,
564–572. doi: 10.1542/peds.111.3.564
Dubester, K. A., and Braun, B. G. (1995). Psychometric properties of
the dissociative experiences scale. J. Nerv. Ment. Dis. 183, 231–235.
doi: 10.1097/00005053-199504000-00008
Felitti, V. J., Anda, R. F., Nordenberg, D., Williamson, D. F., Spitz, A. M., Edwards,
V., et al. (1998). Relationship of childhood abuse and household dysfunction to
many of the leading causes of death in adults. Am. J. Prev. Med. 14, 245–258.
doi: 10.1016/S0749-3797(98)00017-8
Frischholz, E. J., Braun, B. G., Sachs, R. G., Hopkins, L., Schaeffer, D. M., Lewis,
J., et al. (1990). The dissociative experiences scale: further replication and
validation. Dissoc. Prog. Dissoc. Disord. 3, 151–153.
Grant, B. F., Saha, T. D., Ruan, W. J., Goldstein, R. B., Chou, S. P., Jung, J., et al.
(2016). Epidemiology of DSM-5 drug use disorder. JAMA Psychiatry 73, 39–47.
doi: 10.1001/jamapsychiatry.2015.2132
Green, J. G., McLaughlin, K. A., Berglund, P. A., Gruber, M. J., Sampson,
N. A., Zaslavsky, A. M., et al. (2010). Childhood adversities and
adult psychiatric disorders in the national comorbidity survey
replication I: associations with first onset of DSM-IV disorders.
Arch. Gen. Psychiatry 67, 113–123. doi: 10.1001/archgenpsychiatry.
2009.186
Hase, M. (2010). “CravEx: an EMDR approach to treat substance abuse and
addiction,” in Eye Movement Desensitization and Reprocessing (EMDR) Scripted
Protocols: Special Populations, eds M. Luber and M. Luber (New York, NY:
Springer Publishing Co), 467–488. Available online at: http://search.ebscohost.
com/login.aspx?direct=true&db=psyh&AN=2009-16776-037&site=ehost-live
Frontiers in Psychology | www.frontiersin.org 7 January 2018 | Volume 8 | Article 2333
Carletto et al. Add-On EMDR in Patients with SUD
Hase, M., Schallmayer, S., and Sack, M. (2008). EMDR reprocessing of the
addiction memory: pretreatment, posttreatment, and 1-month follow-up. J.
EMDR Pract. Res. 2, 170–179. doi: 10.1891/1933-3196.2.3.170
Jeffries, F. W., and Davis, P. (2013). What is the role of eye movements in
eye movement desensitization and reprocessing (EMDR) for post-traumatic
stress disorder (PTSD)? a review. Behav. Cogn. Psychother. 41, 290–300.
doi: 10.1017/S1352465812000793
Knipe, J. (2010). “Dysfunctional positive affects: to assist clients with unwanted
avoidance defenses,” in Eye Movement Desensitization and Reprocessing
(EMDR) Scripted Protocols: Special Populations, eds M. Luber and M.
Luber (New York, NY: Springer Publishing Co.), 451–452. Available online
at: http://search.ebscohost.com/login.aspx?direct=true&db=psyh&AN=2009-
16776-033&site=ehost-live
Koob, G. F. (2013). Addiction is a reward deficit and stress surfeit disorder. Front.
Psychiatry 4:72. doi: 10.3389/fpsyt.2013.00072
Koob, G. F., and Volkow, N. D. (2016). Neurobiology of addiction: a neurocircuitry
analysis. Lancet Psychiatry 3, 760–773. doi: 10.1016/S2215-0366(16)00104-8
Lee, J., Kim, J. K., and Wachholtz, A. (2015). The benefit of heart rate variability
biofeedback and relaxation training in reducing trait anxiety. Hanguk Simni
Hakhoe Chi Kongang Korean. 20, 391–408.
LeTendre, M. L., and Reed, M. B. (2017). The effect of adverse childhood
experience on clinical diagnosis of a substance use disorder: results
of a nationally representative study. Subst. Use Misuse 52, 689–697.
doi: 10.1080/10826084.2016.1253746
Markus, W., de Weert-van Oene, G. H., Becker, E. S., and DeJong, C. A. J.
(2015). A multi-site randomized study to compare the effects of Eye Movement
Desensitization and Reprocessing (EMDR) added to TAU versus TAU to
reduce craving and drinking behavior in alcohol dependent outpatients: study
protocol. BMC Psychiatry 15:15. doi: 10.1186/s12888-015-0431-z
Markus, W., and Hornsveld, H. K. (2017). EMDR Interventions in Addiction. J.
EMDR Pract. Res. 11, 3–29. doi: 10.1891/1933-3196.11.1.3
Miller, R. (2010). The feeling-state theory of impulse-control disorders
and the impulse-control disorder protocol. Traumatology 16, 2–10.
doi: 10.1177/1534765610365912
Mills, K. L., Lynskey,M., Teesson,M., Ross, J., andDarke, S. (2005). Post-traumatic
stress disorder among people with heroin dependence in the Australian
treatment outcome study (ATOS): prevalence and correlates. Drug Alcohol
Depend. 77, 243–249. doi: 10.1016/j.drugalcdep.2004.08.016
Murphy, A., Steele, M., Dube, S. R., Bate, J., Bonuck, K., Meissner, P., et al. (2014).
Adverse Childhood Experiences (ACEs) questionnaire and Adult Attachment
Interview (AAI): implications for parent child relationships. Child Abuse Negl.
38, 224–233. doi: 10.1016/j.chiabu.2013.09.004
Nardo, D., Högberg, G., Lanius, R. A., Jacobsson, H., Jonsson, C., Hällström,
T., et al. (2013). Gray matter volume alterations related to trait dissociation
in PTSD and traumatized controls. Acta Psychiatr. Scand. 128, 222–233.
doi: 10.1111/acps.12026
National Collaborating Centre for Mental Health (UK) (2005). Post-Traumatic
Stress Disorder: The Management of PTSD in Adults and Children in Primary
and Secondary Care. Leicester: Gaskell. Available online at: http://www.ncbi.
nlm.nih.gov/books/NBK56494/ (Accessed June 24, 2015).
Pagani, M., Amann, B. L., Landin-Romero, R., and Carletto, S. (2017). Eye
movement desensitization and reprocessing and slow wave sleep: a putative
mechanism of action. Front. Psychol. 8:1935. doi: 10.3389/fpsyg.2017.01935
Pagani, M., Di Lorenzo, G., Monaco, L., Daverio, A., Giannoudas, I., La
Porta, P., et al. (2015). Neurobiological response to EMDR therapy
in clients with different psychological traumas. Front. Psychol. 6:1614.
doi: 10.3389/fpsyg.2015.01614
Pagani, M., Di Lorenzo, G., Verardo, A. R., Nicolais, G., Monaco, L., Lauretti, G.,
et al. (2012). Neurobiological correlates of EMDR monitoring - an EEG study.
PLoS ONE 7:e45753. doi: 10.1371/journal.pone.0045753
Perez-Dandieu, B., and Tapia, G. (2014). Treating trauma in addiction
with EMDR: a pilot study. J. Psychoactive Drugs 46, 303–309.
doi: 10.1080/02791072.2014.921744
Popky, A. J. (2005). “DeTUR, an urge reduction protocol for addictions and
dysfunctional behaviors,” in EMDR Solutions: Pathways to Healing, ed R.
Shapiro (New York, NY: Norton), 167–188.
Popky, A. J. (2010). “The desensitization of triggers and urge reprocessing
(DeTUR) protocol,” in EyeMovement Desensitization and Reprocessing (EMDR)
Scripted Protocols: Special Populations, eds M. Luber and M. Luber (New York,
NY: Springer Publishing Co.), 489–511.
Prinz, U., Nutzinger, D. O., Schulz, H., Petermann, F., Braukhaus, C., and
Andreas, S. (2013). Comparative psychometric analyses of the SCL-90-R and
its short versions in patients with affective disorders. BMC Psychiatry 13:104.
doi: 10.1186/1471-244X-13-104
Reynolds, M., Hinchliffe, K., Asamoah, V., and Kouimtsidis, C. (2011). Trauma
and post-traumatic stress disorder in a drug treatment community service.
Psychiatrist 35, 256–260. doi: 10.1192/pb.bp.110.030379
Reynolds, M., Mezey, G., Chapman, M., Wheeler, M., Drummond, C., and
Baldacchino, A. (2005). Co-morbid post-traumatic stress disorder in a
substance misusing clinical population. Drug Alcohol Depend. 77, 251–258.
doi: 10.1016/j.drugalcdep.2004.08.017
Roberts, N. P., Roberts, P. A., Jones, N., and Bisson, J. I. (2015). Psychological
interventions for post-traumatic stress disorder and comorbid substance use
disorder: a systematic review and meta-analysis. Clin. Psychol. Rev. 38, 25–38.
doi: 10.1016/j.cpr.2015.02.007
Shapiro, F. (2001). Eye Movement Desensitization and Reprocessing (EMDR): Basic
Principles, Protocols, and Procedures, 2nd Edn. New York, NY: Guilford Press.
Shapiro, F. (2014). The role of eye movement desensitization and reprocessing
(EMDR) therapy in medicine: addressing the psychological and physical
symptoms stemming from adverse life experiences. Perm. J. 18, 71–77.
doi: 10.7812/TPP/13-098
Spielberger, C. D., Gorsuch, R. L., Lushene, R., Vagg, P. R., and Jacobs, G. A.
(1983).Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting
Psychologists Press.
Valiente-Gómez, A., Moreno-Alcázar, A., Treen, D., Cedrón, C., Colom, F., Pérez,
V., et al. (2017). EMDR beyond PTSD: A Systematic Literature Review. Front.
Psychol. 8:1668. doi: 10.3389/fpsyg.2017.01668
van der Hart, O., Groenendijk, M., Gonzalez, A., Mosquera, D., and Solomon, R.
(2013). Dissociation of the personality and EMDR therapy in complex trauma-
related disorders: applications in the stabilization phase. J. EMDR Pract. Res. 7,
81–94. doi: 10.1891/1933-3196.7.2.81
Van Etten, M. L., and Taylor, S. (1998). Comparative efficacy of treatments for post-
traumatic stress disorder: a meta-analysis. Clin. Psychol. Psychother. 5, 126–144.
doi: 10.1002/(SICI)1099-0879(199809)5:3<126::AID-CPP153>3.0.CO;2-H
Vøllestad, J., Sivertsen, B., and Nielsen, G. H. (2011). Mindfulness-based stress
reduction for patients with anxiety disorders: evaluation in a randomized
controlled trial. Behav. Res. Ther. 49, 281–288. doi: 10.1016/j.brat.2011.
01.007
Wang, Y. P., and Gorenstein, C. (2013). Psychometric properties of the beck
depression inventory-II: a comprehensive review. Rev. Bras. Psiquiatr. 35,
416–431. doi: 10.1590/1516-4446-2012-1048
Weiss, D. S., and Marmar, C. R. (1997). “The impact of event scale-revised,” in
Assessing psychological Trauma and PTSD, eds J. P. Wilson and T. M. Keane
(New York, NY: Guilford Press), 399–411.
World Health Organization (WHO) (2013). Guidelines for the Management of
Conditions Specifically Related to Stress. Geneva: WHO.
Conflict of Interest Statement: IF is the president of EMDR Europe Association
and the president of EMDR Italy Association. SC, LO, and MP have been invited
speakers in national and international EMDR conferences.
The other authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
The handling Editor declared a shared affiliation, though no other collaboration,
with several of the authors, SC, FO, and LO, and states that the process nevertheless
met the standards of a fair and objective review.
Copyright © 2018 Carletto, Oliva, Barnato, Antonelli, Cardia, Mazzaferro, Raho,
Ostacoli, Fernandez and Pagani. This is an open-access article distributed under the
terms of the Creative Commons Attribution License (CC BY). The use, distribution or
reproduction in other forums is permitted, provided the original author(s) or licensor
are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Psychology | www.frontiersin.org 8 January 2018 | Volume 8 | Article 2333
